VERONA PHARMA PLC – New Higher Dose RPL554 Clinical Trial in Asthma – Trading Markets (press release)


Proactive Investors UK

VERONA PHARMA PLC – New Higher Dose RPL554 Clinical Trial in Asthma
Trading Markets (press release)
This study is the first of two further trials with RPL554 in patients with allergic asthma. Based on the results, it will determine the dosage used in a
Verona Pharma starts Asthma drug trialProactive Investors UK
STOCKS NEWS UK-Verona gains positive update on key drugLondon South East
Verona Pharma up 20% on new drug trialStock Market Wire
Trading Markets (press release)
all 11 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *